GlassScriptPhysician profile
Chris C Hart
NPI 1003034091
$20,113.78
in general payments reported to CMS, 2019-2025
42 companies · $511 in 2025
The $511 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $13K · 2021: $4,010 · 2022: $911 · 2023: $799 · 2024: $335 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,600 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.92 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,424.37 | 2019-2022 | |
| Abbvie INC. | $871.14 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $425.30 | 2021-2025 | |
| Coopersurgical, INC. | $343.49 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $295.09 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $233.17 | 2019-2025 | Acessa Provu System, Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $202.20 | 2021-2024 | Nexplanon |
| Lupin INC. | $179.00 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $169.83 | 2019-2020 | |
| Biogen, INC. | $148.18 | 2025 | Zurzuvae |
| Pfizer INC. | $140.69 | 2019-2024 | |
| Axonics, INC. | $135.72 | 2022-2023 | Axonics |
| Evofem Biosciences, INC. | $127.44 | 2021-2025 | Phexxi, Solosec, Phexx |
| Agile Therapeutics, INC. | $123.73 | 2021-2022 | |
| Myovant Sciences INC. | $123.42 | 2021-2022 |
Show all 41 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.